INNOVENT MEDICAL SOLUTIONS
Innovent specializes in developing non-invasive airway clearance solutions. The company was founded in 2003 and is headquartered in Israel.
INNOVENT MEDICAL SOLUTIONS
Industry:
Air Transportation Automotive Autonomous Vehicles
Founded:
2003-06-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.innoventmedical.com
Status:
Active
Technology used in webpage:
Apache GoDaddy DNS GoDaddy GoDaddy Email GoDaddy CDN
Similar Organizations
Current Employees Featured
Official Site Inspections
http://www.innoventmedical.com
- Host name: by-multacom.com
- IP address: 142.171.120.134
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Innovent Medical Solutions"
Innovent Medical Solutions - Crunchbase
Innovent specializes in developing non-invasive airway clearance solutions. The company was founded in 2003 and is headquartered in Israel.See details»
Innovia Medical: Medical Devices | Worldwide Distribution
Innovia Medical supplies medical devices to over 70 different nations worldwide. We work internationally with healthcare organizations and medical device distributors and have …See details»
Innovent Global Careers and Employment - Indeed
Find out what works well at Innovent Global from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and …See details»
Innovent
Innovent Biologics is a leading biopharmaceutical company dedicated to developing innovative medicines for major diseases.See details»
Innoventmedical.com
At Innoventmedical.com, we believe that creativity is the most valuable asset of an advertising agency. Our innovative approach and out-of-the-box thinking drive impactful campaigns that …See details»
Innovent Global, Inc. | LinkedIn
Innovent Global, Inc. | 1,024 followers on LinkedIn. "INNOVENT your career." | With more than 20 years of staffing and healthcare experience, INNOVENT GLOBAL has become a …See details»
Meet the Team - Innovent Global
At Innovent Global, we have an amazing team with years of experience in healthcare staffing. Your satisfaction is our priority, and we always look to go above and beyond to surpass your …See details»
Press Release - Innovent Bio
Dec 19, 2023 Our mission is to improve the lives of people with cancer. We are supported by leading life sciences investors and have built an organization with deep oncology drug …See details»
Leader in China Biotech With Solid Commercial Potential
Aug 29, 2024 Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. …See details»
Innovent Receives NMPA Breakthrough Therapy Designation for …
May 7, 2024 Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality …See details»
Press Release - Innovent Bio
Aug 25, 2022 Upgrading commercial model and platform to 2.0 stage, actively seek to establish a more agile and lean organization with more refined, systematic and scientific management, …See details»
Innovent Biologics and Sanofi Enter Strategic Collaboration to ...
Aug 4, 2022 Collaboration to accelerate the development and access of oncology medicines for cancer patients in China Clinical trial programs combining two of Sanofi's...See details»
Innovent Biologics, Inc. - Investors & Media
Innovent Biologics, a leading biopharmaceutical company in China and a world-class biopharmaceutical company that makes high quality biopharmaceutical drugs affordable to …See details»
China's Innovent Biologics secures over $300 million investment …
Aug 5, 2022 Innovent Biologics Inc said on Friday Paris-based Sanofi SA would invest HK$2.42 billion ($307.88 million) in the biopharmaceutical group to jointly develop two cancer drugs in …See details»
Innovent to Present Clinical Data of Multiple Novel Molecules at …
Aug 29, 2024 Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality …See details»
Innovent and AnHeart Therapeutics Announce the National …
Nov 22, 2023 In June 2021, Innovent and AnHeart entered into an exclusive license agreement for the co-development and commercialization of taletrectinib in Greater China, including …See details»
Innovent Announces Primary Endpoint Met in the Phase 3 Clinical …
Feb 20, 2024 Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality …See details»
Press Release - AnHeart Therapeutics
Nov 22, 2023 Press Release for AnHeart Therapeutics; a clinical stage global biopharmaceutical company developing a pipeline of novel next-generation precision oncology therapeutics for …See details»
Press Release: Sanofi and Innovent Biologics enter strategic ...
Aug 4, 2022 Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China Collaboration to …See details»
Innovent and IASO Bio Enhance Strategic Collaboration in Cell …
Jul 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...See details»